Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response
Summary
This summary is machine-generated.Hepatitis C virus NS5A protein inhibits interferon-alfa antiviral effects in cells. This inhibition is not solely determined by the ISDR region and does not correlate with patient treatment outcomes.
Area Of Science
- Virology
- Immunology
- Hepatology
Background
- Chronic hepatitis C virus (HCV) infection treatment with interferon-alfa (IFN-alpha) yields poor long-term response rates.
- The NS5A protein region, known as the Interferon Sensitivity Determining Region (ISDR), is implicated in treatment outcomes for some HCV patients.
- NS5A protein is known to inhibit PKR and interfere with IFN-alpha's action in human cells.
Purpose Of The Study
- To investigate the inhibitory effects of NS5A protein from both responders and non-responders to IFN-alpha therapy.
- To determine if NS5A from non-responders exhibits greater inhibition of IFN-alpha's antiviral activity in vitro.
Main Methods
- Cloning and expression of NS5A from well-characterized IFN-alpha responders and non-responders in a human fibroblast cell line.
- Controlled NS5A expression levels to assess its impact on IFN-alpha's protective effects against encephalomyocarditis virus.
- Investigated the role of ISDR variations in modulating NS5A's inhibitory activity.
Main Results
- NS5A expression effectively blocked the antiviral actions of IFN-alpha in human cells, with inhibition intensity correlating to expression levels.
- ISDR sequence variations showed minimal impact on IFN-alpha inhibition.
- Significant differences in inhibitory capacity were observed between NS5A clones from IFN-alpha responders versus non-responders, with clones from responders being more inhibitory.
Conclusions
- The NS5A protein's inhibition of IFN-alpha's antiviral effects is not exclusively regulated by the ISDR.
- In vitro inhibitory activity of NS5A does not directly correlate with patient responses to IFN-alpha treatment.
View abstract on PubMed